SLCO1B1 and myopathy: In previous reports, the SLCO1B1 genetic variants were proved to be relevant to the response to drugs transported by OATP1B1, such as statin-induced myopathy, irinotecan-induced toxicities, methotrexate clearance42, 43, 44, 45, 46, 47, 48.